← Back to Volume 6, Issue 4

Preclinical Evaluation of a Ratio-Optimized BALIMONT Multi-Strain Synbiotic Platform for Intestinal Flora Regulation

Anas Ziraoui, William Fairfax · Noah Parker
Vol.6, No.4, pp.73-77, 2026 DOI: 10.62051/ijphmr.v6n4.11 April 29, 2026
Download PDF
Abstract: We evaluated a BALIMONT multi-strain synbiotic platform built around Bifidobacterium longum, Bifidobacterium adolescentis, and Lactiplantibacillus plantarum, with fructooligosaccharide and stachyose as prebiotic supports. We reorganized the formulation dossier into a journal-style manuscript and interpreted the disclosed mouse outcomes alongside current probiotic and synbiotic literature. Across the disclosed high-dose groups, all six ratio-optimization embodiments increased bifidobacteria and lactobacilli while reducing Escherichia coli; total short-chain fatty acids and butyrate rose in parallel with lower cecal pH, higher fecal-pellet output, and greater fecal moisture. Within the B. longum-enriched branch, the 3:1:1 ratio produced the strongest reported metabolic profile, including total SCFA 93.27 μmol/g and butyrate 19.51 μmol/g. Within the B. adolescentis-enriched branch, the 1:3:1 ratio reached total SCFA 89.48 μmol/g, butyrate 18.81 μmol/g, bifidobacteria 11.38 lgCFU/g, and cecal pH 5.52. Published evidence indicates that FOS increases colonic bifidobacteria in humans, raffinose-family oligosaccharides can be utilized by bifidobacteria and lactobacilli, and synbiotics can raise Lactobacillus and propionate in healthy adults [4-8]. Taken together, these results support BALIMONT as a strain-defined, freeze-dried, prebiotic-supported synbiotic platform whose strongest disclosed effects were observed when bifidobacterial weighting was increased.
Keywords: BALIMONT, Bifidobacterium longum, Bifidobacterium adolescentis, Lactiplantibacillus plantarum, Synbiotic, Short-chain fatty acids, Freeze-drying, Intestinal flora
APA Citation: Anas Ziraoui, William Fairfax · Noah Parker (2026). Preclinical Evaluation of a Ratio-Optimized BALIMONT Multi-Strain Synbiotic Platform for Intestinal Flora Regulation. International Journal of Public Health and Medical Research, 6(4), 73-77. https://doi.org/10.62051/ijphmr.v6n4.11

References

  1. ATCC. Bifidobacterium longum subsp. longum Reuter, ATCC 15707. Strain E194b (Variant a), adult intestine type strain. ATCC product catalog. Accessed March 29, 2026.
  2. ATCC. Bifidobacterium adolescentis Reuter, ATCC 15703. Strain E194a (Variant a), adult intestine type strain. ATCC product catalog. Accessed March 29, 2026.
  3. ATCC. Lactiplantibacillus plantarum (Orla-Jensen) Zheng et al., ATCC 14917. Strain Lp 39 [IAM 12477], whole-genome-sequenced type strain. ATCC product catalog. Accessed March 29, 2026.
  4. Mills S, Yang B, Smith GJ, Stanton C, Ross RP. Efficacy of Bifidobacterium longum alone or in multi-strain probiotic formulations during early life and beyond. Gut Microbes. 2023; 15(1):2186098. doi:10.1080/19490976.2023.2186098.
  5. Dou Y, Yu X, Luo Y, Chen B, Ma D, Zhu J. Effect of fructooligosaccharides supplementation on the gut microbiota in human: a systematic review and meta-analysis. Nutrients. 2022; 14(16):3298. doi:10.3390/nu14163298.
  6. Kanwal F, Ren D, Kanwal W, Ding M, Su J, Shang X. The potential role of nondigestible raffinose family oligosaccharides as prebiotics. Glycobiology. 2023; 33(4):274-288. doi:10.1093/glycob/cwad015.
  7. Cosier DJ, Lambert K, Neale EP, Probst Y, Charlton K. The effect of oral synbiotics on the gut microbiota and inflammatory biomarkers in healthy adults: a systematic review and meta-analysis. Nutr Rev. 2025; 83(2):e4-e24. doi:10.1093/nutrit/nuae002.
  8. Van der Schoot A, Helander C, Whelan K, Dimidi E. Probiotics and synbiotics in chronic constipation in adults: a systematic review and meta-analysis of randomized controlled trials. Clin Nutr. 2022; 41(12):2759-2777. doi:10.1016/j.clnu.2022.10.015.
  9. Facchin S, Vitulo N, Delogu F, et al. Short-chain fatty acids and human health: from metabolic pathways to current therapeutic implications. Life (Basel). 2024; 14(5):559. doi:10.3390/life14050559.
  10. Mann ER, Lam YK, Uhlig HH. Short-chain fatty acids: linking diet, the microbiome and immunity. Nat Rev Immunol. 2024; 24(8):577-595. doi:10.1038/s41577-024-01014-8.